There were 2,088 press releases posted in the last 24 hours and 440,824 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
INmune Bio Provides Update Regarding Global Alzheimer’s Phase II Clinical Trial and Clinical Hold Issued by the United States FDA

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image